Apo CIII Proteoforms, Plasma Lipids, and Cardiovascular Risk in MESA

By sjmartinez • July 28, 2023

Sinari S, Koska J, Hu Y, Furtado J, Jensen MK, Budoff MJ, Nedelkov D, McClelland RL, Billheimer D, Reaven P. Apo CIII Proteoforms, Plasma Lipids, and Cardiovascular Risk in MESA. Arterioscler Thromb Vasc Biol. 2023 Aug;43(8):1560-1571. doi: 10.1161/ATVBAHA.123.319035. Epub 2023 Jun 15. PMID: 37317850.

Tags: apolipoprotein, Cardiology/Epi, cardiovascular disease, Harbor UCLA, lipids, Publications, risk

David E. Haines, MD, September 1, 1954, to February 10, 2024

Daoud EG, Shivkumar K, Mehta NK. David E. Haines, MD, September 1, 1954, to February 10, 2024. Heart Rhythm. 2024 May;21(5):710-711. doi: 10.1016/j.hrthm.2024.03.016. PMID: 38692819.

Effects of Empagliflozin on vascular and skeletal mineralization in Hyperlipidemic mice

Kalanski S, Pradhan S, Hon A, Xia Y, Safvati N, Rivera JC, Lu M, Demer LL, Tintut Y. Effects of Empagliflozin on vascular and skeletal[...]

David E. Haines, MD, September 1, 1954, to February 10, 2024

Daoud EG, Shivkumar K, Mehta NK. David E. Haines, MD, September 1, 1954, to February 10, 2024. JACC Clin Electrophysiol. 2024 Apr 19:S2405-500X(24)00185-3. doi: 10.1016/j.jacep.2024.03.004.[...]